" "
Satellite Banner
Technology
Networks
Scientific Communities
 
Become a Member | Sign in
Home>Events>This Event
  Events - April 2013


Immunology: A Pathway Through the Maze

30 Apr 2013 - 01 May 2013 - University of Oxford



Bookmark and Share


Immunology is a rapidly developing subject with wide-ranging implications for the pharmaceutical, healthcare and biotechnology industries.

Common questions include, for example: How does the immune system defend the body against infection? What goes wrong when autoimmunity develops? How can undesirable responses be controlled?

Team leaders, R&D directors, and researchers at the bench all need to understand the latest developments in immunology and their implications for drug discovery and development as well as disease treatment. An understanding of the fundamental features of the immune system is essential not only for those who work in areas directly related to infection and immunity, but also for those working in the development of biopharmaceuticals, vaccines and antibody therapy, who wish to exploit the technological advances that have resulted from our increased insight into how the system functions.

As well as offering a path through the immunology maze, the course will emphasize the R&D opportunities for therapeutic intervention that arise from recent advances in immunology, for example the use of therapeutic antibodies and recombinant molecules as potential drug treatments. After the introductory session, each lecture will begin by covering the basic concepts of a particular area of immunology; these will then be developed in such a way that participants are rapidly brought an understanding of the most recent findings.

Oxford is a leading centre in the creative development and application of the theory and techniques of immunology in collaboration with industry. The presenters are leading scientists in their fields and use these techniques in their day-to-day research. They work in the Nuffield Department of Surgery at the University of Oxford.



Further information
Scientific News
Head Injury Patients have Protein Clumps Associated with Alzheimer’s Disease
Scientists have revealed that protein clumps associated with Alzheimer's disease are also found in the brains of people who have had a head injury.
Exposure to Air Pollution 30 Years Ago Associated with Increased Risk of Death
Exposure to air pollution more than 30 years ago may still affect an individual's mortality risk today, according to new research from Imperial College London.
More Then 1 in 20 U.S. Children have Dizziness and Balance Problems
Researchers at NIH have found that girls have a higher prevalence of dizziness and balance problems compared to boys, 5.7 percent and 5.0 percent.
Biosensors on Demand
New strategy results in custom "designer proteins" for sensing a variety of molecules.
Low-Cost, Portable NQR Spectroscopy
A researcher at Case Western Reserve University is developing a low-cost, portable prototype designed to detect tainted medicines and food supplements that otherwise can make their way to consumers. The technology can authenticate good medicines and supplements.
Structure of Brain Plaques in Huntington's
Researchers at the University of Pittsburgh School of Medicine have shown that the core of the protein clumps found in the brains of people with Huntington's disease have a distinctive structure, a finding that could shed light on the molecular mechanisms underlying the neurodegenerative disorder.
Insights into the Function of the Main Class of Drug Targets
About thirty percent of all medical drugs such as beta-blockers or antidepressants interact with certain types of cell surface proteins called G protein coupled receptors.
Spero Therapeutics Announces $30 Million Series B Preferred Financing
Company has announced financing of $30 million to support development of novel therapies to treat gram-negative bacterial infections.
Unique Mechanism for a High-Risk Leukemia
Researchers uncovered the aberrant mechanism underlying a notoriously treatment-resistant acute lymphoblastic leukemia subtype; findings offer lessons for understanding all cancers.
Visualizing a Cancer Drug Target at Atomic Resolution
Using cryo-electron microscopy, researchers were able to view, in atomic detail, the binding of a potential small molecule drug to a key protein in cancer cells.
Scroll Up
Scroll Down
Skyscraper Banner

Skyscraper Banner
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
2,900+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
4,200+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FOR FREE!